ArticleslgStudy

chemistry

Pridopidine

Pridopidine is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pridopidine rather than just read about it. In short: Pridopidine (developmental code name PL-101) is an orally administrated small molecule investigational drug. Pridopidine is a selective and potent sigma-1 receptor agonist.

Pridopidine — main illustration
Pridopidine — illustration

Key takeaways

  • Pridopidine belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Pridopidine to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Pridopidine from memory before moving on to harder problems.

Reference excerpt

Pridopidine (developmental code name PL-101) is an orally administrated small molecule investigational drug. Pridopidine is a selective and potent sigma-1 receptor agonist. It is being developed by Prilenia Therapeutics and is currently in late-stage clinical development for Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS).

Mechanism of action Pridopidine works by binding and activating an intracellular protein called the sigma-1 receptor (S1R) located at the mitochondria-associated membrane (MAM) of the endoplasmic reticulum. The S1R regulates key cellular processes crucial to neuronal health and survival. Selective activation of the S1R is a promising therapeutic target for treating neurodegenerative and neurodevelopmental disorders. Pridopidine activation of the S1R demonstrates neuroprotective effects in numerous models of neurodegenerative diseases including HD, ALS, Glaucoma, Parkinson's disease (PD) and Alzheimer's disease (AD). Pridopidine exhibits a neuroprotective effect against mutant Huntingtin (mHTT)-induced cell death in mouse primary HD neurons and human HD-induced pluripotent stem cells. It restores the impaired synaptic plasticity in HD neurons, enhances mitochondrial function, upregulates BDNF transport and secretion, reduces endoplasmic reticulum stress and restores dendritic spine abnormalities in HD and AD models. In models of ALS, pridopidine protects neuron-muscle connectivity and restores muscle integrity and contractility. These beneficial effects are exclusively mediated by the S1R as either deletion of this gene, or selective inhibition of its function, completely abolish pridopidine's beneficial effects. Initially, the primary target of pridopidine was postulated to be the dopamine D2/D3 receptors. However, in vitro binding assays show that pridopidine has high affinity for the S1R and low affinity for other targets including the dopamine D2/D3 receptors, adrenergic a2c receptor and the Sigma-2 receptor. Furthermore, selective and robust occupancy of the S1R, with no or negligible occupancy of the D2/D3 receptors was demonstrated by in vivo positron emission tomography (PET) imaging studies in rats and human.

Chemistry

Analogues Analogues of pridopidine include ordopidine, OSU-6162, and 3-PPP, among others.

Potential indications

Huntington's disease Huntington's disease (HD) is a progressive fatal neurodegenerative disease caused by a mutation in the Huntingtin gene (expanded CAG repeat > 35). The disease is characterized by progressive motor abnormalities, cognitive decline, and psychiatric and behavioral symptoms. Adult-onset HD usually begins between 35 and 45 years of age. Following onset, motor, cognitive and functional outcomes steadily decline over 15 to 20 years, ultimately leading to a state of profound incapacity and death. The disease is inherited in an autosomal dominant manner, and thus each child of a parent with HD has a 50% chance of inheriting the mutated HD gene. For patients and their families, maintaining functional capacity is vital as it translates to a patient's ability to maintain their occupation, continue to manage their daily lives, and live independently. A meta-analysis of four randomized controlled trials (RCTs) involving 1,130 patients (816 in the pridopidine group and 314 in the placebo group) found that pridopidine led to a slight, though not statistically significant, improvement in overall motor symptoms, as measured by the Unified Huntington's Disease Rating Scale Total Motor Score, compared to placebo. However, the drug significantly improved voluntary movements, as indicated by the Modified Motor Score. Pridopidine was generally well tolerated, with no significant differences in adverse events or serious adverse events compared to placebo. The findings suggest that pridopidine has potential for treating motor symptoms in HD, with a favorable safety profile, warranting further clinical trials to confirm its benefits.

Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis (ALS) is a devastating progressive fatal neurodegenerative disease characterized by upper and lower motor neuron degeneration. Over time this progressive loss of motor function leads to losing the ability to speak, eat, move and eventually breathe. A phase 2 trial of the drug in ALS patients concluded in 2023 and did not reach its end points. However, one specific sub-group in the trial, patients with early and rapid onset of the disease's symptoms, did show significantly statistical improvement of their symptoms. As a result, a phase 3 trial was approved and began in early 2026. The phase 3 trial is expected to enroll 500 subjects.

Society and culture

Legal status In July 2025, the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) recommended the refusal of a marketing authorization for Nurzigma, a medicine intended for the treatment of adults with Huntington's disease.

See also List of investigational antipsychotics List of investigational Parkinson's disease drugs Ordopidine and seridopidine

References

Illustrations

Pridopidine illustration

Worked examples

Example 1 — a first encounter with Pridopidine

Start with the simplest possible case. Write down what Pridopidine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pridopidine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pridopidine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pridopidine

In research
Pridopidine appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Pridopidine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Pridopidine is common in secondary-school and first-year university syllabi. It links to neighbouring topics 4-Phenylpiperidines, D2 antagonists, Huntington's disease, so understanding it makes those chapters shorter.
In everyday life
Look for Pridopidine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pridopidine in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Pridopidine means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Pridopidine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pridopidine in simple terms?

Pridopidine (developmental code name PL-101) is an orally administrated small molecule investigational drug. Pridopidine is a selective and potent sigma-1 receptor agonist.

Why does Pridopidine matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pridopidine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pridopidine.

Tags

  • 4-Phenylpiperidines
  • D2 antagonists
  • Huntington's disease
  • Methylsulfonylbenzene derivatives
  • Propyl compounds
  • Sigma agonists

Keep exploring